Clinical pharmacy services in a pediatric hematology/oncology clinic: A description and assessment

Canadian Journal of Hospital Pharmacy

Volumn 52, Issue 1, 1999, Pages 18-23

  Taylor, Tracey L ^a   Dupuis, L Lee ^a   Nicksy, Darcy ^a   Girvan, Cindy ^a  

^a NONE

Author keywords

Bone marrow transplant; Oncology; Pediatrics; Pharmaceutical care

Indexed keywords

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL PHARMACY; COST CONTROL; DRUG CHOICE; DRUG INDICATION; DRUG OVERDOSE; FEMALE; HEALTH CARE DELIVERY; HUMAN; INFANT; MALE; PATIENT CARE; PATIENT COMPLIANCE; PHARMACEUTICAL CARE; PHARMACIST; PRESCRIPTION;

EID: 0032892848     PISSN: 00084123     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Davies NM, Spaven JR, Chambers CR. Comprehensive clinical pharmacy documentation in an out-patient cancer facility. Can J Hosp Pharm 1992;45:107-12.
2. Furmaga EM. Pharmacist management of a hyperlipidemia clinic. Am J Hosp Pharm 1993; 50:91-5.
3. Por CP. Implementation of pharmaceutical care in a family practice clinic. Can J Hosp Pharm [abstract] 1995;48:139.
4. Lobas NH, Lepinski PW, Abramowitz PW. Effects of pharmaceutical care on medication cost and quality of patient care in an ambulatory-care clinic. Am J Hosp Pharm 1992; 49: 1681-8.
5. Price SO, Newnham MA. Physician perceptions of clinical pharmacy encounters in a family practice clinic. Top Hosp Pharm Manage 1994; 14(3): 13-20.
6. Kaplan B, Mason N, Shimp L, Ascione FJ. Chronic hemodialysis patients. Part I: Characterization and drug-related problems. Ann Pharmacother 1994; 28: 316-9.
7. Kaplan B, Shimp LA, Mason NA, Ascione FJ. Chronic hemodialysis patients. Part II: Reducing drug related problems through the application of focused drug therapy review program. Ann Pharmacother 1994; 28: 320-4.
8. Tang I, Vrahnos D, Hatoum H, Lau A. Effectiveness of clinical pharmacist interventions in a hemodialysis unit. Clin Ther 1993; 15(2):459-69.
9. Kootsikas, ME, Hayes C, Thompson JF, Perlman S, Brinkman JH. Role of a pharmacist in a seizure clinic. Am J Hosp Pharm 1990;47:2478-82.
10. Warnock AC, Rimland D. The provision of pharmaceutical care in a Veterans' Affairs medical centre outpatient HIV clinic. Hosp Pharm 1994; 29: 114-6, 119-20.
11. Chant C, Chin T. A needs assessment study on the provision of pharmaceutical care in the HIV clinic, [abstract] Can J Hosp Pharm 1994;47:42.
12. Raehl CL, Bond CA, Pitterle ME. Ambulatory pharmacy services affiliated with acute care hospitals. Pharmacother 1993; 13: 618-25.
13. Mason JM, Colley CA. Effectiveness of an ambulatory care clinical pharmacist. Ann Pharmacother 1993; 27: 555-9.
14. Mason JD, Colley CA. Effectiveness of an ambulatory care clinical pharmacist: a controlled trial. Ann Pharmacother 1993; 27:555-9.
15. Koecheler JA, Abramowitz PW, Swim SE, Daniels CE. Indicators for the selection of ambulatory patients who warrant pharmacist monitoring. Am J Hosp Pharm 1989; 46: 729-32.
16. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990; 47: 533-43.
17. Rosenthal R. Meta-analytic procedures for social research. Beverly Hills, CA: Sage Publications 1984.
18. Bond CA, Monson R. Sustained improvement in drug documentation, compliance, and disease control. A four-year analysis of an ambulatory care model. Arch Intern Med 1984; 144:1159-62.
19. Tebbi CK. Treatment compliance in childhood and adolescence. Cancer 1993; 71:3441-9.
20. Smith SD, Rosen D, Trueworthy RC, Lowman JT. A reliable method for evaluating drug compliance in children with cancer. Cancer 1979;43:169-73.
21. Festa RS, Tamaroff MH, Chasalow F, Lanzkowsky P. Therapeutic adherence to oral medication regimens by adolescents with cancer 1. laboratory assessment. J Pediatr 1992; 120:807-11.
22. Tebbi CK, Cummings KM, Zevon MA, Smith L, Richards M, Mallon J. Compliance of pediatric and adolescent cancer patients. Cancer 1986; 58:1179-84.
23. Deady JE, Lepinski PW, Abramowitz PW. Measuring the ability of clinical pharmacists to effect drug therapy changes in a family practice clinic using prognostic indicators. Hosp Pharm 1991; 26: 93-7.
24. Strong DK, Tsang GWY. Focus and impact of pharmacists' interventions. Can J Hosp Pharm 1993; 46:101-8.
25. Nelson AA. Research design: measurement, reliability, and validity. Am J Hosp Pharm 1980; 37:851-7.